An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma
Bristol-Myers Squibb · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017